Navigation Links
WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing
Date:12/22/2009

SHANGHAI, Dec. 22 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, today announced the winners of its third Life Science and Chemistry Awards, held on December 20, 2009, at the China World Hotel in Beijing.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The theme of this year's awards was Biology in Drug Discovery. The selection panel was comprised of ten scholars with extensive industry expertise:

    -- Han Qide, honorary Chairman of the selection panel, Vice Chairman of
       the Standing Committee of the National People's Congress of China,
       Chairman of the Jiusan Society, President of the Chinese Society for
       Science and Technology, Dean of the Medical School of Peking
       University, and Academician of the Chinese Academy of Sciences
    -- Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech
    -- Dr. Shuhui Chen, Chief Scientific Officer of WuXi PharmaTech
    -- Dr. Qiang Lu, Vice President of Biology of WuXi PharmaTech
    -- Dr. Xiaodong Wang, Director of the National Institute of Biological
       Science in Beijing and Academician of the National Academy of
       Sciences in the United States
    -- Dr. Chen Kaixian, President of Shanghai University of Traditional
       Chinese Medicine and Academician of the Chinese Academy of Sciences
    -- Dr. Saijuan Chen, Director of the State Key Laboratory of Medical
       Genomics, Executive Director of the Shanghai Institute of Hematology,
       and Academician of the Chinese Academy of Engineering
    -- Dr. Yi Rao, Dean of the School of Life Sciences at Peking University
    -- Dr. Yigong Shi, Dean of the School of Life Sciences at Tsinghua
       University
    -- Dr. Gang Pei, President of Tongji University and Academician of the
       Chinese Academy of Sciences

Sixteen winners were selected through a rigorous, objective, and transparent evaluation process that began in July.

    The First Prize winners are:

    -- Dr. Yongfeng Shang, Director of the Department of Biochemistry and
       Molecular Biology of the School of Basic Medical Science at Peking
       University
    -- Dr. Jiahuai Han, Professor of the School of Life Sciences at Xiamen
       University and Dr. Baofeng Yang, President of Harbin Medical
       University
    -- Dr. Baofeng Yang, President of Harbin Medical University

Dr. Yongfeng Shang is a newly selected Academician of the Chinese Academy of Sciences. Dr. Baofeng Yang is a newly selected Academician of the Chinese Academy of Engineering.

    The Second Prize winners are:

    -- Dr. Hongbing Shu, Dean of College of Life Sciences at Wuhan
       University
    -- Dr. Xiangyin Kong from the Shanghai Institutes for Biological
       Sciences of the Chinese Academy of Sciences and Group Leader of
       Molecular Genetics of the Institute of Health Sciences of Shanghai
       Jiaotong University School of Medicine
    -- Dr. Jianping Ding from the Institute of Biochemistry and Cell
       Biology of the Shanghai Institutes for Biological Sciences of the
       Chinese Academy of Sciences
    -- Dr. Tianle Xu from the Institute of Neuroscience of the Shanghai
       Institutes for Biological Sciences of the Chinese Academy of
       Sciences

    The Third Prize winners are:

    -- Dr. Bing Hu from the School of Life Sciences of the University of
       Science and Technology of China
    -- Dr. Yuanying Jiang, Dean of the School of Medicine at Second
       Military Medical University
    -- Dr. Jijie Cai from the National Institute of Biological Sciences,
       Beijing
    -- Dr. Xiang Gao, Vice Dean and Professor of the Medical School of
       Nanjing University
    -- Dr. Zehong Miu from the Shanghai Institute of Materia Medica of the
       Chinese Academy of Sciences
    -- Dr. Shaorong Gao from the National Institute of Biological Sciences,
       Beijing
    -- Dr. Xuechu Zhen from the Shanghai Institute of Materia Medica of the
       Chinese Academy of Sciences
    -- Dr. Jianguo Chen, Executive Vice Dean of the Research and
       Development Office and Director of the Department of Pharmacology of
       Tongji Medical College at Huazhong University of Science and
       Technology
    -- Jie Tang from the Institute of Biophysics of the Chinese Academy of
       Sciences

"I am honored to receive the WuXi PharmaTech Life Science and Chemistry Award," said Dr. Yongfeng Shang, the First Prize Winner. "This award recognizes my research work and inspires me to delve deeper into the study of pharmaceutical research and development. As a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, WuXi PharmaTech founded this award to encourage scientists working in pharmaceutical research and development and to promote basic scientific research and innovation related to life science and chemistry. I will continue to spare no efforts to make my contributions to the life science industry."

Han Qide, Vice Chairman of the Standing Committee of the National People's Congress, and Mr. Zhang Huaixi, Vice Chairman of the Tenth Chinese People's Political Consultative Conference, attended the awards ceremony, presented the awards, and congratulated the winners, encouraging them to continue their contributions to China's pharmaceutical research and scientific development.

"We are honored to host the third WuXi PharmaTech Life Science and Chemistry Awards Ceremony," said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "Without the robust talent pool of scientists available in China and the support of our society, WuXi could not have built its broad platform of research capabilities. We want to express our gratitude to everyone who supports our company and its contributions to the pharmaceutical industry of China. WuXi will continue to expand its service portfolio to transform drug research and development and ultimately to save lives and improve human health."

    For more information, please contact:

    WuXi PharmaTech (Cayman) Inc.

     Ronald Aldridge (for investors)
     Director of Investor Relations
     Tel:   +1-201-585-2048
     Email: ir@wuxiapptec.com

     Stephanie Liu (for the media)
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +86-21-5046-4362
     Email: pr@wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening
2. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
3. Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline
4. WuXi PharmaTech Announces Second-Quarter 2009 Results
5. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
6. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
7. WuXi PharmaTech Receives Award from BASF
8. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
9. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
10. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
11. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... for more than 150 years, continues today to pursue the highest level of ... of analytical instruments: the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... cell treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols ... patients from around the world. , The new GSCG clinic is headed ...
(Date:2/10/2016)... Early-career researchers from Indonesia , ... Uganda and Yemen honored ... Indonesia , Nepal , ... are being honored for their accomplishments in nutrition, psychiatry, biotechnology, ... young women scientists who are pursuing careers in agriculture, biology and medicine ...
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
Breaking Biology Technology:
(Date:1/20/2016)... 2016 A market that just keeps on ... the explosion in genomics knowledge. Learn all about it ... range of dynamic trends are pushing market growth and ... - pharmacogenomics - pathogen evolution - next generation sequencing ... greater understanding of the role of genetic material in ...
(Date:1/15/2016)... Puerto Rico , Jan. 15, 2016 ... big and small to find new ways to ensure ... culture. iOS and Android ... based on biometrics, transforming it into a hardware authorization ... that users swipe their fingerprint on their KodeKey enabled ...
(Date:1/11/2016)... 2016  higi, the leading retail and omni-channel community ... web and mobile, today announced it has closed ... investors. --> --> ... innovate higi,s health platform – its network of ... including expanding services and programs to retail partners ...
Breaking Biology News(10 mins):